Alf Håkon Lystad

Dr. Alf Håkon Lystad


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
TMThomas J. Melia
Thomas J. Melia
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
ASAnne Simonsen
Anne Simonsen
Autophagosome biogenesis involves de novo formation of a membrane that elongates to sequester cytoplasmic cargo and closes to form a double-membrane vesicle (an autophagosome). This process has remained enigmatic since its initial discovery >50 yr ago, but our understanding of the mechanisms involved in autophagosome biogenesis has increased substantially during the last 20 yr. Several key questions do remain open, however, including, What determines the site of autophagosome nucleation? What is the origin and lipid composition of the autophagosome membrane? How is cargo sequestration regulated under nonselective and selective types of autophagy? This review provides key insight into the core molecular mechanisms underlying autophagosome biogenesis, with a specific emphasis on membrane modeling events, and highlights recent conceptual advances in the field.

18 February 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
SCSven R. Carlsson
Sven R. Carlsson
LBLaura R. de la Ballina
Laura R. de la Ballina
KKKarlina J. Kauffman
Karlina J. Kauffman
SNShanta Nag
Shanta Nag
ASAnne Simonsen
Anne Simonsen

23 May 2019 in Autophagy
Verified
Journal Article
Closed access
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
SCSven R. Carlsson
Sven R. Carlsson
ASAnne Simonsen
Anne Simonsen
The machinery that decorates autophagic membranes with lipid-conjugated LC3/GABARAP is not yet fully understood. We recently reported the purification of the full-length ATG12–ATG5-ATG16L1 complex, and in reconstitution experiments with purified ATG7, ATG3, and LC3/GABARAP in vitro, together with rescue experiments in knockout cells, important aspects of the complete lipidation reaction were revealed. Hitherto unobserved membrane-binding regions in ATG16L1 were found, contributing to properties that explain the crucial role of this protein in membrane targeting and LC3/GABARAP lipidation in macroautophagy/autophagy and other related processes.

20 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMichael J. Munson
Michael J. Munson
BMBenan J. Mathai
Benan J. Mathai
MNMatthew Yoke Wui Ng
Matthew Yoke Wui Ng
LTLaura Trachsel-Moncho
Laura Trachsel-Moncho
LBLaura R. de la Ballina
Laura R. de la Ballina
ASAnne Simonsen
Anne Simonsen
The mechanisms involved in programmed or damage-induced removal of mitochondria by mitophagy remains elusive. Here, we have screened for regulators of PRKN-independent mitophagy using an siRNA library targeting 197 proteins containing lipid interacting domains. We identify Cyclin G-associated kinase (GAK) and Protein Kinase C Delta (PRKCD) as regulators of PRKN-independent mitophagy, with both being dispensable for PRKN-dependent mitophagy and starvation-induced autophagy. We demonstrate that the kinase activity of both GAK and PRKCD are required for efficient mitophagy in vitro, that PRKCD is present on mitochondria, and that PRKCD facilitates recruitment of ULK1/ATG13 to early autophagic structures. Importantly, we demonstrate in vivo relevance for both kinases in the regulation of basal mitophagy. Knockdown of GAK homologue (gakh-1) in C. elegans or knockout of PRKCD homologues in zebrafish led to significant inhibition of basal mitophagy, highlighting the evolutionary relevance of these kinases in mitophagy regulation.

25 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
ASAnne Simonsen
Anne Simonsen
Since their initial discovery around two decades ago, the yeast autophagy-related (Atg)8 protein and its mammalian homologues of the light chain 3 (LC3) and γ-aminobutyric acid receptor associated proteins (GABARAP) families have been key for the tremendous expansion of our knowledge about autophagy, a process in which cytoplasmic material become targeted for lysosomal degradation. These proteins are ubiquitin-like proteins that become directly conjugated to a lipid in the autophagy membrane upon induction of autophagy, thus providing a marker of the pathway, allowing studies of autophagosome biogenesis and maturation. Moreover, the ATG8 proteins function to recruit components of the core autophagy machinery as well as cargo for selective degradation. Importantly, comprehensive structural and biochemical in vitro studies of the machinery required for ATG8 protein lipidation, as well as their genetic manipulation in various model organisms, have provided novel insight into the molecular mechanisms and pathophysiological roles of the mATG8 proteins. Recently, it has become evident that the ATG8 proteins and their conjugation machinery are also involved in intracellular pathways and processes not related to autophagy. This review focuses on the molecular functions of ATG8 proteins and their conjugation machinery in autophagy and other pathways, as well as their links to disease.

6 July 2023 in The EMBO Journal
Verified
Journal Article
Open access
NKNamrita Kaur
Namrita Kaur
LBLaura Rodriguez de la Ballina
Laura Rodriguez de la Ballina
HHHåvard Styrkestad Haukaas
Håvard Styrkestad Haukaas
MTMaria Lyngaas Torgersen
Maria Lyngaas Torgersen
MRMaja Radulovic
Maja Radulovic
Alf Håkon LystadAlf Håkon Lystad
Alf Håkon Lystad
Cells use noncanonical autophagy, also called conjugation of ATG8 to single membranes (CASM), to label damaged intracellular compartments with ubiquitin-like ATG8 family proteins in order to signal danger caused by pathogens or toxic compounds. CASM relies on E3 complexes to sense membrane damage, but so far, only the mechanism to activate ATG16L1-containing E3 complexes, associated with proton gradient loss, has been described. Here, we show that TECPR1-containing E3 complexes are key mediators of CASM in cells treated with a variety of pharmacological drugs, including clinically relevant nanoparticles, transfection reagents, antihistamines, lysosomotropic compounds, and detergents. Interestingly, TECPR1 retains E3 activity when ATG16L1 CASM activity is obstructed by the Salmonella Typhimurium pathogenicity factor SopF. Mechanistically, TECPR1 is recruited by damage-induced sphingomyelin (SM) exposure using two DysF domains, resulting in its activation and ATG8 lipidation. In vitro assays using purified human TECPR1-ATG5-ATG12 complex show direct activation of its E3 activity by SM, whereas SM has no effect on ATG16L1-ATG5-ATG12. We conclude that TECPR1 is a key activator of CASM downstream of SM exposure.